Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis.

Saldanha IJ, Akinyede O, McKoy NA, Robinson KA.

Cochrane Database Syst Rev. 2013 Dec 9;(12):CD009421. doi: 10.1002/14651858.CD009421.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(11):CD009421.

PMID:
24323825
2.

Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis.

Saldanha IJ, Akinyede O, Robinson KA.

Cochrane Database Syst Rev. 2015 Nov 10;(11):CD009421. doi: 10.1002/14651858.CD009421.pub3. Review.

PMID:
26559561
3.

Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.

Penninga L, Penninga EI, Møller CH, Iversen M, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2013 May 31;(5):CD008817. doi: 10.1002/14651858.CD008817.pub2. Review.

PMID:
23728681
4.

Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.

Hong T, Zhang M, Fan J.

Cochrane Database Syst Rev. 2015 Oct 12;(10):CD009698. doi: 10.1002/14651858.CD009698.pub2. Review.

PMID:
26457607
5.

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients.

Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2014 Jun 5;(6):CD010253. doi: 10.1002/14651858.CD010253.pub2. Review.

PMID:
24901467
6.

Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients.

Penninga L, Wettergren A, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD008852. doi: 10.1002/14651858.CD008852.pub2. Review.

PMID:
22419339
7.

Antibody induction versus corticosteroid induction for liver transplant recipients.

Penninga L, Wettergren A, Wilson CH, Chan AW, Steinbrüchel DA, Gluud C.

Cochrane Database Syst Rev. 2014 May 31;(5):CD010252. doi: 10.1002/14651858.CD010252.pub2. Review.

PMID:
24880007
8.

Cyclosporin versus tacrolimus for liver transplanted patients.

Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005161. Review.

PMID:
17054241
9.

Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.

Montero N, Webster AC, Royuela A, Zamora J, Crespo Barrio M, Pascual J.

Cochrane Database Syst Rev. 2014 Sep 15;(9):CD007669. doi: 10.1002/14651858.CD007669.pub2. Review.

PMID:
25220222
10.
11.

Inhaled mannitol for cystic fibrosis.

Nolan SJ, Thornton J, Murray CS, Dwyer T.

Cochrane Database Syst Rev. 2015 Oct 9;(10):CD008649. doi: 10.1002/14651858.CD008649.pub2. Review.

PMID:
26451533
12.

Interleukin 2 receptor antagonists for kidney transplant recipients.

Webster AC, Ruster LP, McGee R, Matheson SL, Higgins GY, Willis NS, Chapman JR, Craig JC.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003897. doi: 10.1002/14651858.CD003897.pub3. Review.

PMID:
20091551
13.

Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.

Fairfield C, Penninga L, Powell J, Harrison EM, Wigmore SJ.

Cochrane Database Syst Rev. 2015 Dec 15;(12):CD007606. doi: 10.1002/14651858.CD007606.pub3. Review.

PMID:
26666504
14.

Vitamin D supplementation for cystic fibrosis.

Ferguson JH, Chang AB.

Cochrane Database Syst Rev. 2014 May 14;(5):CD007298. doi: 10.1002/14651858.CD007298.pub4. Review.

PMID:
24823922
15.

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Robinson KA, Odelola OA, Saldanha IJ, McKoy NA.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD007743. doi: 10.1002/14651858.CD007743.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;(6):CD007743.

PMID:
22336832
16.

Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.

Jain K, Wainwright C, Smyth AR.

Cochrane Database Syst Rev. 2016 Jan 21;(1):CD009530. doi: 10.1002/14651858.CD009530.pub3. Review.

PMID:
26797965
17.

Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosis.

Freitas DA, Dias FA, Chaves GS, Ferreira GM, Ribeiro CT, Guerra RO, Mendonça KM.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD010297. doi: 10.1002/14651858.CD010297.pub2. Review.

PMID:
25756796
18.

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Robinson KA, Odelola OA, Saldanha IJ, McKoy NA.

Cochrane Database Syst Rev. 2013 Jun 5;(6):CD007743. doi: 10.1002/14651858.CD007743.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;(5):CD007743.

PMID:
23737087
19.

Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.

Webster A, Woodroffe RC, Taylor RS, Chapman JR, Craig JC.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD003961. Review.

PMID:
16235347
20.

Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.

Jain K, Wainwright C, Smyth AR.

Cochrane Database Syst Rev. 2013 Dec 23;(12):CD009530. doi: 10.1002/14651858.CD009530.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;(1):CD009530.

PMID:
24363033

Supplemental Content

Support Center